(Q42162407)

17 October 2017

title

Transient effect of topical treatment of cutaneous leishmaniasis with imiquimod (English)

1 reference

17 October 2017

main subject

cutaneous leishmaniasis

1 reference

Josef Seeberger

1

1 reference

17 October 2017

Saleh Daoud

series ordinal

2

1 reference

17 October 2017

Johannes Pammer

series ordinal

3

1 reference

17 October 2017

publication date

1 July 2003

1 reference

International Journal of Dermatology

17 October 2017

published in

1 reference

17 October 2017

volume

42

1 reference

17 October 2017

issue

7

1 reference

17 October 2017

page(s)

576-579

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2003.01955.X

17 October 2017

1 reference

21 January 2018

Cutaneous leishmaniasis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2003.01955.X

Immunomodulatory and pharmacologic properties of imiquimod

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2003.01955.X

Divergent expression of inflammatory dermal chemokines in cutaneous leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2003.01955.X

Topical immunomodulators--progress towards treating inflammation, infection, and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2003.01955.X

Imiquimod in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2003.01955.X

Successful treatment of drug-resistant cutaneous leishmaniasis in humans by use of imiquimod, an immunomodulator

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2003.01955.X

10.1046/J.1365-4362.2003.01955.X

21 January 2018

Identifiers

DOI

1 reference

17 October 2017

1 reference